http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9923214-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa8a2c27cd33efd7af20dfc3b5cb1f2e |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4712 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate | 1998-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39237d455c69348c0161c6bb36a4aa98 |
publicationDate | 1999-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-9923214-A1 |
titleOfInvention | Compositions and methods for enhancing cardiac contractility mediated by myocyte p2 purinoceptors and models thereof |
abstract | A recombinant myocyte comprising at least one introduced nucleic acid encoding a P2 purinoceptor, such as a P2X4 or P2X6 purinoceptor, and a method of determining whether a compound affects cardiac contractility in an animal are provided. Furthermore, a method of augmenting cardiac contractility and a method of treating heart failure are included in the invention, as is a kit comprising one or more recombinant myocytes and an instructional material. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0135967-A1 |
priorityDate | 1997-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.